Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 663, doi. 10.1177/0961203316630116
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2016 AND VI 25 AND IP 6
Results: 14
1
2
Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 645, doi. 10.1177/0961203316629554
- By:
- Publication type:
- Article
3
Eppur Si Muove: vitamin D is essential in preventing and modulating SLE.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 563, doi. 10.1177/0961203316629001
- By:
- Publication type:
- Article
4
Drugs used in incident systemic lupus erythematosus – results from the Finnish nationwide register 2000–2007.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 666, doi. 10.1177/0961203316628998
- By:
- Publication type:
- Article
5
Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 652, doi. 10.1177/0961203315625460
- By:
- Publication type:
- Article
6
Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
7
Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 637, doi. 10.1177/0961203315624022
- By:
- Publication type:
- Article
8
Improving definitions for an index of cumulative organ damage in patients with the antiphospholipid syndrome (DIAPS).
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
9
Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 593, doi. 10.1177/0961203315622823
- By:
- Publication type:
- Article
10
Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 627, doi. 10.1177/0961203315622821
- By:
- Publication type:
- Article
11
Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 617, doi. 10.1177/0961203315622819
- By:
- Publication type:
- Article
12
Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 602, doi. 10.1177/0961203315622817
- By:
- Publication type:
- Article
13
Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 573, doi. 10.1177/0961203315622275
- By:
- Publication type:
- Article
14
Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 6, p. 582, doi. 10.1177/0961203315608254
- By:
- Publication type:
- Article